{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:35:10Z","timestamp":1760027710699,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Surviving Sepsis Guidelines suggest the use of vasopressin in case of catecholamine-refractory septic shock. Terlipressin (TP) as a V<jats:sub>1<\/jats:sub>-selective AVP analogue is a potential alternative, though data regarding the first-line administration in septic shock are scarce. The present study explored and compared the effects of first-line vs. second-line infusion of TP or sole norepinephrine regarding organ function, fluid and norepinephrine requirements and survival in fulminant ovine septic shock. Peritoneal sepsis was induced in 23 ewes after laparotomy and faecal withdrawal from the caecum. After onset of shock, causal and supportive sepsis therapy (antibiotics, peritoneal lavage, fluids and open-label norepinephrine) was performed in all animals. Concurrently, animals were randomized to receive 0.9% sodium chloride (control group) or TP (2\u2009\u00b5g\u2219kg<jats:sup>\u22121<\/jats:sup>\u2219h<jats:sup>\u22121<\/jats:sup>, first-line group) after shock onset. In the second-line TP group, TP (2\u2009\u00b5g\u2219kg<jats:sup>\u22121<\/jats:sup>\u2219h<jats:sup>\u22121<\/jats:sup>) was started once norepinephrine requirements exceeded 0.5\u2009\u00b5g\u2219kg<jats:sup>\u22121<\/jats:sup>\u2219min<jats:sup>\u22121<\/jats:sup>. No significant differences were found between groups regarding survival, haemodynamics as well as fluid- and catecholamine-requirements. Kidney function and electron microscopic kidney injury were comparable between groups. In the present model of fulminant ovine septic shock, first-line TP infusion had no significant effect on fluid and norepinephrine requirements or organ dysfunction as compared to second-line TP infusion or placebo.<\/jats:p>","DOI":"10.1038\/s41598-018-25570-x","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T09:13:54Z","timestamp":1525166034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of first-line and second-line terlipressin versus sole norepinephrine in fulminant ovine septic shock"],"prefix":"10.1038","volume":"8","author":[{"given":"Tim G.","family":"Kampmeier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip H.","family":"Arnemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura M.","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6391-1341","authenticated-orcid":false,"given":"Karsten","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian W.","family":"Rehberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Ertmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"25570_CR1","first-page":"017","volume":"18","author":"A Rhodes","year":"2017","unstructured":"Rhodes, A. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 18, 017\u20134683 (2017).","journal-title":"Intensive Care Med"},{"key":"25570_CR2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/0310057X0903700212","volume":"37","author":"CR Jenkins","year":"2009","unstructured":"Jenkins, C. R., Gomersall, C. D., Leung, P. & Joynt, G. M. Outcome of patients receiving high dose vasopressor therapy: a retrospective cohort study. Anaesth Intensive Care 37, 286\u2013289 (2009).","journal-title":"Anaesth Intensive Care"},{"key":"25570_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4037\/ajcc2013748","volume":"22","author":"D Dopp-Zemel","year":"2013","unstructured":"Dopp-Zemel, D. & Groeneveld, A. B. High-dose norepinephrine treatment: determinants of mortality and futility in critically ill patients. Am J Crit Care 22, 22\u201332 (2013).","journal-title":"Am J Crit Care"},{"key":"25570_CR4","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1097\/01.CCM.0000059722.94182.79","volume":"31","author":"MW Dunser","year":"2003","unstructured":"Dunser, M. W. et al. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Crit Care Med 31, 1394\u20131398 (2003).","journal-title":"Crit Care Med"},{"key":"25570_CR5","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1097\/01.CCM.0000094260.05266.F4","volume":"31","author":"S Klinzing","year":"2003","unstructured":"Klinzing, S., Simon, M., Reinhart, K., Bredle, D. L. & Meier-Hellmann, A. High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 31, 2646\u20132650 (2003).","journal-title":"Crit Care Med"},{"key":"25570_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00101-005-0958-3","volume":"55","author":"G Luckner","year":"2006","unstructured":"Luckner, G. et al. Vasopressin as adjunct vasopressor for vasodilatory shock due to non-occlusive mesenteric ischemia. Anaesthesist 55, 283\u2013286, https:\/\/doi.org\/10.1007\/s00101-005-0958-3 (2006).","journal-title":"Anaesthesist"},{"key":"25570_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/cc4845","volume":"10","author":"G Luckner","year":"2006","unstructured":"Luckner, G. et al. Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome. Crit Care 10, R40 (2006).","journal-title":"Crit Care"},{"key":"25570_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell, J. A. et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358, 877\u2013887 (2008).","journal-title":"N Engl J Med"},{"key":"25570_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon, A. C. et al. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. Jama 316, 509\u2013518 (2016).","journal-title":"Jama"},{"key":"25570_CR10","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1007\/s00134-009-1470-z","volume":"35","author":"S Rehberg","year":"2009","unstructured":"Rehberg, S. et al. Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock. Intensive Care Med 35, 1286\u20131296, https:\/\/doi.org\/10.1007\/s00134-009-1470-z (2009).","journal-title":"Intensive Care Med"},{"key":"25570_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00011-010-0299-9","volume":"60","author":"M Lange","year":"2011","unstructured":"Lange, M. et al. Effects of two different dosing regimens of terlipressin on organ functions in ovine endotoxemia. Inflamm Res 60, 429\u2013437, https:\/\/doi.org\/10.1007\/s00011-010-0299-9 (2011).","journal-title":"Inflamm Res"},{"key":"25570_CR12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00134-007-0946-y","volume":"34","author":"M Lange","year":"2008","unstructured":"Lange, M., Ertmer, C. & Westphal, M. Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis. Intensive Care Med 34, 821\u2013832 (2008).","journal-title":"Intensive Care Med"},{"key":"25570_CR13","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.5754\/hge10550","volume":"59","author":"P Svoboda","year":"2012","unstructured":"Svoboda, P. et al. Terlipressin in the treatment of late phase catecholamine-resistant septic shock. Hepato-gastroenterology 59, 1043\u20131047, https:\/\/doi.org\/10.5754\/hge10550 (2012).","journal-title":"Hepato-gastroenterology"},{"key":"25570_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/cc7990","volume":"13","author":"A Morelli","year":"2009","unstructured":"Morelli, A. et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care 13, R130 (2009).","journal-title":"Crit Care"},{"key":"25570_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/CCM.0000000000001380","volume":"44","author":"X He","year":"2016","unstructured":"He, X. et al. A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock. Crit Care Med 44, 23\u201331, https:\/\/doi.org\/10.1097\/ccm.0000000000001380 (2016).","journal-title":"Crit Care Med"},{"key":"25570_CR16","first-page":"26","volume":"26","author":"MO Maybauer","year":"2014","unstructured":"Maybauer, M. O. et al. The Selective Vasopressin Type 1a Receptor Agonist Selepressin (FE 202158) Blocks Vascular Leak in Ovine Severe Sepsis. Crit Care Med 26, 26 (2014).","journal-title":"Crit Care Med"},{"key":"25570_CR17","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/bja\/aew101","volume":"116","author":"S Weibel","year":"2016","unstructured":"Weibel, S. et al. Efficacy and safety of intravenous lidocaine for postoperative analgesia and recovery after surgery: a systematic review with trial sequential analysis. Br J Anaesth 116, 770\u2013783 (2016).","journal-title":"Br J Anaesth"},{"key":"25570_CR18","first-page":"30027","volume":"11","author":"T Kampmeier","year":"2017","unstructured":"Kampmeier, T. et al. Provision of physiological data and reference values in awake and anaesthetized female sheep aged 6-12 months. Vet Anaesth Analg 11, 30027\u201330022 (2017).","journal-title":"Vet Anaesth Analg"},{"key":"25570_CR19","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CCM.0b013e318206d403","volume":"39","author":"C Ertmer","year":"2011","unstructured":"Ertmer, C. et al. Effects of balanced crystalloid vs. 0.9% saline-based vs. balanced 6% tetrastarch infusion on renal function and tubular integrity in ovine endotoxemic shock. Crit Care Med 39, 783\u2013792, https:\/\/doi.org\/10.1097\/CCM.0b013e318206d403 (2011).","journal-title":"Crit Care Med"},{"key":"25570_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/AAP.0b013e31823ebc74","volume":"37","author":"Y Ma","year":"2012","unstructured":"Ma, Y., Mazumdar, M. & Memtsoudis, S. G. Beyond repeated-measures analysis of variance: advanced statistical methods for the analysis of longitudinal data in anesthesia research. Reg Anesth Pain Med 37, 99\u2013105 (2012).","journal-title":"Reg Anesth Pain Med"},{"key":"25570_CR21","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int (2) Suppl, 1\u2013138 (2012)."},{"key":"25570_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama 315, 801\u2013810 (2016).","journal-title":"Jama"},{"key":"25570_CR23","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00134-011-2148-x","volume":"37","author":"A Morelli","year":"2011","unstructured":"Morelli, A. et al. Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock. Intensive Care Med 37, 963\u2013969, https:\/\/doi.org\/10.1007\/s00134-011-2148-x (2011).","journal-title":"Intensive Care Med"},{"key":"25570_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00134-007-0971-x","volume":"34","author":"D Yildizdas","year":"2008","unstructured":"Yildizdas, D., Yapicioglu, H., Celik, U., Sertdemir, Y. & Alhan, E. Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children. Intensive Care Med 34, 511\u2013517, https:\/\/doi.org\/10.1007\/s00134-007-0971-x (2008).","journal-title":"Intensive Care Med"},{"key":"25570_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2040-7378-3-14","volume":"3","author":"TG Kampmeier","year":"2011","unstructured":"Kampmeier, T. G., Ertmer, C. & Rehberg, S. Translational research in sepsis - an ultimate challenge? Exp Transl Stroke Med 3, 14, https:\/\/doi.org\/10.1186\/2040-7378-3-14 (2011).","journal-title":"Exp Transl Stroke Med"},{"key":"25570_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/aas.12130","volume":"57","author":"C Lundblad","year":"2013","unstructured":"Lundblad, C., Axelberg, H. & Grande, P. O. Treatment with the sphingosine-1-phosphate analogue FTY 720 reduces loss of plasma volume during experimental sepsis in the rat. Acta Anaesthesiol Scand 57, 713\u2013718 (2013).","journal-title":"Acta Anaesthesiol Scand"},{"key":"25570_CR27","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1055\/s-2003-42931","volume":"41","author":"KD Dohler","year":"2003","unstructured":"Dohler, K. D., Walker, S., Mentz, P., Forssmann, K. & Staritz, M. Vasoconstrictive Therapies for Bleeding Esophageal Varices and their Mechanisms of Action. Z Gastroenterol 41, 1001\u20131016 (2003).","journal-title":"Z Gastroenterol"},{"key":"25570_CR28","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.3748\/wjg.v16.i48.6046","volume":"16","author":"C Eipel","year":"2010","unstructured":"Eipel, C., Abshagen, K. & Vollmar, B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol 16, 6046\u20136057 (2010).","journal-title":"World J Gastroenterol"},{"key":"25570_CR29","doi-asserted-by":"crossref","unstructured":"Krejci, V., Hiltebrand, L. B., Jakob, S. M., Takala, J. & Sigurdsson, G. H. Vasopressin in septic shock: effects on pancreatic, renal, and hepatic blood flow. Crit Care 11 (2007).","DOI":"10.1186\/cc6197"},{"key":"25570_CR30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1042\/CS20110483","volume":"122","author":"MT Rademaker","year":"2012","unstructured":"Rademaker, M. T., Charles, C. J., Nicholls, M. G. & Richards, A. M. Haemodynamic, endocrine and renal actions of adrenomedullin 5 in an ovine model of heart failure. Clin Sci (Lond) 122, 429\u2013437, https:\/\/doi.org\/10.1042\/CS20110483 (2012).","journal-title":"Clin Sci (Lond)"},{"key":"25570_CR31","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/bja\/aem295","volume":"99","author":"C Ertmer","year":"2007","unstructured":"Ertmer, C. et al. Exogenous adrenomedullin prevents and reverses hypodynamic circulation and pulmonary hypertension in ovine endotoxaemia. Br J Anaesth 99, 830\u2013836, https:\/\/doi.org\/10.1093\/bja\/aem295 (2007).","journal-title":"Br J Anaesth"},{"key":"25570_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","volume":"36","author":"RP Dellinger","year":"2008","unstructured":"Dellinger, R. P. et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36, 296\u2013327 (2008).","journal-title":"Crit Care Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25570-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25570-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25570-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:00:19Z","timestamp":1671598819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25570-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["25570"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-25570-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"assertion":[{"value":"26 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Tim-Gerald Kampmeier received travel reimbursements and honoraria as a consultant from Fresenius Kabi Germany. Sebastian Rehberg has received travel fees provided by Orion Pharma and Amomed Pharma and is Medical Advisor for Amomed Pharma and Fresenius Kabi Germany. For the remaining authors no financial and non-financial competing interests were declared.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7105"}}